Maker’s co-founder proposes roadmap for Endgame rollout.MakerDAO is gearing up to accelerate the adoption of its Endgame overhaul.On March 12, Rune Christensen, the co-founder...
Verdane, a European specialist growth investment firm, announced the successful final close of Verdane Edda III (“Edda III” or “the Fund”) at €1.1 billion,...
UK-based financial services company
Cornerstone FS plc (LSE: CSFS) announced significant growth in its 2023
financial results, showing 100% revenue increase to £9.6 million. The company
provides...
GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) In 2014, XVIVO introduced an innovative liver technology to the Italian...
Climate Legislation in Asia
Everything you need to know about Climate Legislation in Asia.
China
China has committed to achieving carbon neutrality by 2060. Intending to generate...
The shares
of fintech company Equals Group, which specializes in payments for enterprises
and SMEs, surged more than 11% on Wednesday, reaching their highest...
Scammers have found a new way to
deceive unsuspecting consumers by impersonating major banks despite repeated
warnings dating back to 2021, the Financial Services and Markets...
ARTICLE | RegulationPlus: J&J’s Rybrevant raises the bar and updates from Harbinger, Gritstone, Merck, Immunovant, Evozyne, PTC By BioCentury Staff
September 29, 2023 12:10 AM UTC
FDA Thursday approved late-onset...
A trend in improvement for the dual primary endpoint of overall survival (OS) was observed for datopotamab deruxtecan versus chemotherapy. Data for OS were...